Jamia Hamdard University has withdrawn 150 MBBS seats and 49 postgraduate medical seats for the 2025–26 academic year, effectively eliminating its entire medical admissions quota amid a deeper institutional dispute. The decision followed a Comptroller and Auditor General (CAG) report alleging financial irregularities involving a ₹813 crore diversion from the Hamdard Institute of Medical Sciences & Research (HIMSR) to the Hamdard Education Society—though the institute and sponsoring body deny these claims (Reddit, Shiksha).
Hamdard Education Society has strongly refuted the diversion charge, stating that seat cancellation resulted solely from Jamia Hamdard University’s unilateral affiliation revocation on June 6, 2024, which allegedly violated a Delhi High Court status‑quo order. It emphasized that HIMSR remains accredited, its finances audited by firms like PwC, and no regulatory authority flagged financial or compliance violations (www.ndtv.com).
Students received zero medical seats in the NEET 2025 counselling matrix, prompting public statements from HIMSR on July 21–22, 2025. The institute reassured parents and current students that institutional status and operations remain unaffected pending the legal proceedings between the university and the medical college (Medical Dialogues).
The crisis stems from a longstanding power struggle within the Hamdard family over control of Jamia Hamdard University and HIMSR, which have operated under an autonomy agreement since 2021. The conflict has reportedly disrupted governance and academic functioning, with dual administrative teams and frozen operations reported (tribuneindia.com).
Impact on Students:
- NEET-qualified aspirants lose opportunity to secure seats at HIMSR this year
- Heightened uncertainty and anxiety during counselling and admissions
-
Signals need for oversight in private institutions with deemed‑university status
